-

01:41:42 PM

ELTP Stock News

ELTP - Elite Pharmaceuticals, Inc.

05/11/22 7:00 AM

OTC : ELTP

management

Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today announced the appointment of Robert Chen, CPA/MPA, as its Chief Financial Officer (CFO),

RHEA-AI

neutral

04/04/22 7:00 AM

OTC : ELTP

fda approval

Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that together with Elite's co-development partner, Praxgen Pharmaceuticals LLC, formerly SunGen

RHEA-AI

neutral

02/14/22 6:25 PM

OTC : ELTP

earnings

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the third quarter of

RHEA-AI

neutral

02/09/22 5:15 PM

OTC : ELTP

conferencesearnings

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTC PINK:ELTP), a specialty pharmaceutical company developing niche generic products,

RHEA-AI

neutral

11/15/21 4:45 PM

OTC : ELTP

earnings

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year Ended September 30, 2021 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the second quarter

RHEA-AI

neutral

11/09/21 8:00 PM

OTC : ELTP

conferencesearnings

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,

RHEA-AI

neutral

08/16/21 4:31 PM

OTC : ELTP

earnings

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the first quarter of

RHEA-AI

neutral

08/10/21 4:30 PM

OTC : ELTP

conferencesearnings

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced

RHEA-AI

neutral

06/14/21 5:10 PM

OTC : ELTP

earnings

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31,

RHEA-AI

neutral

06/08/21 4:00 PM

OTC : ELTP

conferencesearnings

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it will release

RHEA-AI

neutral